Evidence map›Paper›PMID 29695417›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.

Jesus A Ocana, Eric Romer, Ravi Sahu, Sven-Christian Pawelzik, Garret A FitzGerald, Mark H Kaplan, Jeffrey B Travers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of Innate Immunity in Allergic Contact Dermatitis: An Update.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Evidence for microvesicle particles in UVB-mediated IL-8 generation in keratinocytes.Journal of clinical and investigative dermatology · 2021
    Article
  9. The Implications of Pruritogens in the Pathogenesis of Atopic Dermatitis.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jesus A OcanaDepartment of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0003-3124-9282
Eric RomerDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435.
Ravi SahuDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435.
Sven-Christian PawelzikDepartment of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104.
Garret A FitzGeraldDepartment of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA 19104.
Mark H KaplanDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0002-2923-8245
Jeffrey B TraversDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435; jeffrey.travers@wright.edu.ORCID 0000-0001-7232-1039
Wright State University · USIndiana University – Purdue University Indianapolis · USTranslational Therapeutics (United States) · US

Funding

Pilot Study: POPULATION PHARMACOLOGYU54HL117798 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HOGENESCH, JOHN B · 2012 to 2016
$18.5M
Platelet Activating Factor and Epidermic CytotoxicityR01HL062996 · NHLBI · WRIGHT STATE UNIVERSITY · PI TRAVERS, JEFFREY B. · 1999 to 2023
$7.2M
Indiana Medical Scientist/Engineer Training ProgramT32GM077229 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN, HERBERT, BRITTNEY-SHEA · 2008 to 2022
$6.0M
Cytokine regulation of skin barrier functionR01AI095282 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2012 to 2022
$4.3M
Th9 cells in immediate hypersensitivityR01AI129241 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2017 to 2021
$2.0M
Oxidized Lipids and UV ImmunosuppressionI01BX000853 · VA · RLR VA MEDICAL CENTER · PI Jeffrey B. Travers · 2011 to 2026
–
BLRD VA I01 BX000853NHLBI NIH HHS R01 HL062996NHLBI NIH HHS U54 HL117798NIAID NIH HHS R01 AI095282NIAID NIH HHS R01 AI129241NIGMS NIH HHS T32 GM077229
6 · The paper itself

Abstract

Platelet-activating factor (PAF) stimulates numerous cell types via activation of the G protein-coupled PAF receptor (PAFR). PAFR activation not only induces acute proinflammatory responses, but it also induces delayed systemic immunosuppressive effects by modulating host immunity. Although enzymatic synthesis and degradation of PAF are tightly regulated, oxidative stressors, such as UVB, chemotherapy, and cigarette smoke, can generate PAF and PAF-like molecules in an unregulated fashion via the oxidation of membrane phospholipids. Recent studies have demonstrated the relevance of the mast cell (MC) PAFR in PAFR-induced systemic immunosuppression. The current study was designed to determine the exact mechanisms and mediators involved in MC PAFR-mediated systemic immunosuppression. By using a contact hypersensitivity model, the MC PAFR was not only found to be necessary, but also sufficient to mediate the immunosuppressive effects of systemic PAF. Furthermore, activation of the MC PAFR induces MC-derived histamine and PGE

Indexed as

AnimalsCarboxy-LyasesCell MovementCyclooxygenase 2Dermatitis, ContactDinoprostoneFemaleImmunosuppression TherapyLymph NodesMaleMast CellsMiceMice, Inbred C57BLPlatelet Activating FactorReceptors, G-Protein-CoupledCarboxy-LyasesCyclooxygenase 2DinoprostonePlatelet Activating FactorReceptors, G-Protein-Coupled

Identifiers

PMID29695417
PMCPMC5988963
OpenAlexW2801503071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.